|
|
||||||||
a Department of Medical and Surgical Critical Care, University of Florence, Florence
b Department of Surgery, University of Verona, Verona, Italy
Accepted for publication September 14, 2009.
* Address correspondence to Dr Politi, Department of Medical and Surgical Critical Care, Azienda Ospedaliero Universitaria Careggi, Viale Morgagni 85, Firenze, I-50134, Italy (Email: leonardo.politi{at}unifi.it).
Background: Extrapleural pneumonectomy is a treatment option for malignant pleural mesothelioma (MPM), but disease recurrence is common. Among different therapeutic options for recurrence, we have found no reports for second surgical procedures.
Methods: We retrospectively evaluated the types and outcomes of surgical management of solid recurrences of MPM, in a series of 74 patients treated with extrapleural pneumonectomy over a 20-year period.
Results: Of 57 patients for whom follow-up data were available, 11 patients experienced recurrent disease in the form of a solid mass, 1.5 to 12 years after the initial treatment; 8 of these patients had sufficiently good clinical conditions to undergo a second surgery with curative intent. Chest wall resection was performed in 4 cases of parietal recurrence, radical retroperitoneal resection was done in 3 cases of retroperitoneal relapse, and segmental resection of the remaining lung was done in one case of pulmonary metastasis. In this latter case, although computed tomographic images showed a solid mass, at surgery the disease was found to have a serosal nature, precluding the possibility of a curative surgery. Median survival after the second surgery was 14.5 months (range, 6 to 29); no association between survival and site of recurrence, age or disease-free interval was found.
Conclusions: In this series, the second surgery did not offer the expected survival benefit of curative treatment strategies and should therefore be considered palliative. Second surgery may be a treatment option in a subset of patients who experience a solid recurrence of MPM that is symptomatic or near vital organs and who cannot undergo additional radiotherapy.
Related Article
Ann. Thorac. Surg. 2010 89: 210-211.
This article has been cited by other articles:
![]() |
S. TAKANEN, B. RESULI, V. GRAZIANO, A. PARISI, R. LISI, N. RAFFETTO, and V. TOMBOLINI Complete Response and Long-term Survival in Malignant Pleural Mesothelioma: Case Report Anticancer Res, April 1, 2012; 32(4): 1485 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rice Invited Commentary Ann. Thorac. Surg., January 1, 2010; 89(1): 210 - 211. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |